These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25906756)

  • 21. Mycophenolate mofetil for ocular myasthenia.
    Chan JW
    J Neurol; 2008 Apr; 255(4):510-3. PubMed ID: 18299952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
    Zimmerman AB; Berger EM; Elmariah SB; Soter NA
    J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressive disorder associated with mycophenolate mofetil.
    Draper HM
    Pharmacotherapy; 2008 Jan; 28(1):136-9. PubMed ID: 18154484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
    Muscle Study Group
    Neurology; 2008 Aug; 71(6):394-9. PubMed ID: 18434639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.
    Mowzoon N; Sussman A; Bradley WG
    J Neurol Sci; 2001 Apr; 185(2):119-22. PubMed ID: 11311292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K; Varikkara M; Santiago C; Forrester JV
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial.
    van Gelder T; Silva HT; de Fijter JW; Budde K; Kuypers D; Tyden G; Lohmus A; Sommerer C; Hartmann A; Le Meur Y; Oellerich M; Holt DW; Tönshoff B; Keown P; Campbell S; Mamelok RD
    Transplantation; 2008 Oct; 86(8):1043-51. PubMed ID: 18946341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.
    Lim AK; Donnan G; Chambers B; Ierino FL
    Intern Med J; 2007 Jan; 37(1):55-9. PubMed ID: 17199845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T; Reis A; Kutkuhn B; Voiculescu A; Sundmacher R
    Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ; Fitzgibbons L; Bruick J; Bunke M; Ault B; Baqi N; Trachtman H; Swinford R
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1173-8. PubMed ID: 17699344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.
    Sollinger HW; Sundberg AK; Leverson G; Voss BJ; Pirsch JD
    Transplantation; 2010 Feb; 89(4):446-51. PubMed ID: 20177347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil as second line immunosuppressant in Myasthenia gravis--a long-term prospective open-label study.
    Hanisch F; Wendt M; Zierz S
    Eur J Med Res; 2009 Aug; 14(8):364-6. PubMed ID: 19666397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation.
    Roan JN; Chou CH; Hsu CH; Wu SY; Huang YC; Yang YJ; Luo CY
    Ann Transplant; 2013 Feb; 18():43-52. PubMed ID: 23792500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons from two trials of mycophenolate mofetil in myasthenia gravis.
    Sanders DB; Siddiqi ZA
    Ann N Y Acad Sci; 2008; 1132():249-53. PubMed ID: 18567876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis.
    Dubal DB; Mueller S; Ruben BS; Engstrom JW; Josephson SA
    Muscle Nerve; 2009 Jun; 39(6):849-50. PubMed ID: 19358236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil therapy in Taiwanese myasthenia gravis.
    Yeh JH; Chen WH; Chiu HC
    Acta Neurol Taiwan; 2008 Sep; 17(3):167-71. PubMed ID: 18975522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.